Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Clinical trial NCT01191749 · TERMINATED
Trial details
- NCT number
- NCT01191749
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.